Cancer

Cancer refers to a group of more than a hundred diseases that can originate in many different parts of the body. Cancer begins in your cells, which are the building blocks of your body.

Metabolic Flexibility in Cancer: How Diet and Nutrition Shape Tumor Survival and Resistance

Cancer cells survive therapy by dynamically rewiring their metabolism in response to nutrient availability, microenvironmental stress, and therapeutic pressure. This article explains how dietary interventions may exploit metabolic flexibility and plasticity to enhance treatment response while accounting for tumor heterogeneity.

Cancer Screening Considerations: Balancing the Benefits and Risks

Using Biomarkers to Detect Cancer

Cancer Symptoms

British Pioneers in Cancer Biology

Hypoxia Markers and Their Importance

Nanostructured toxins for the selective destruction of drug-resistant human CXCR4style+ colorectal cancer stem cells

What is Merkel Cell Carcinoma?

The Biochemistry of Breast Cancer Screening

Cancer Glossary

What is Cancer?

Cancer Diagnosis

See more featured articles »

Cutaneous Manifestations of Internal Malignancy

Metastatic Migration in Cancer may be Influenced by Metabolism

Cured Meats, Nitrates, and Cancer Risk: Why Food Source and Processing Matter

TARDIS: The Improved Method of Detecting Breast Cancer

The Effects of Cancer on Family Life

Effects of Social and Economic Deprivation on Cancer Mortality

Secondary Lung Cancer

CDK9 and Cancer

How Camomile Could Prevent Neutropenia in Pediatric Leukemia Patients

Cancer Management

Cancer Prognosis

Assay for Monitoring and Treating Malignant Brain Tumors

Investigating the Molecular Mechanisms of Cancer

What Causes Cancer?

The Cancer Cell Surface Proteome as a Therapeutic Target

Pediatric Cancer

Insight into Cancer Vaccines

Caring for a Loved One with Cancer

Tyrosine Kinase Inhibitors for Targeted Cancer Therapy

What is the Tumor Microenvironment?

Secondary Brain Cancer

What is Immunochemotherapy?

Hot vs Cold: the differences between tumor types

Myc Mutations and Cancer

Why are Cancer Cell Lines Useful?

Cancer Pain

Cancer Plasticity: The Shape-Shifting Threat Challenging Modern Treatments

Is Cancer a Metabolic Disorder?

Cancer History

Exploiting Enzymes in Cancer Diagnosis and Therapy

Cancer Pathophysiology

What is Tumorigenesis?

Cancer Research

Living with Cancer Pain

Targeted Cancer Therapies

Cancer Epidemiology

Microfluidic cancer treatment screen combined with flow cytometry

What Role do Biobanks Play in Cancer Research?

How Immune Checkpoint Inhibitors have Revolutionized Cancer Treatment

Acidosis and Tumor Progression

Insights into Oncofertility

Cancer Prevention: Lowering your Risk

Cancer Classification

Extracellular Vesicles as Floating Cancer Biomarkers

Discovery of Blood Cancer Cells that show Plasma Cell-Like Differentiation

Overview of Cell Viability and Cytotoxicity

Cancer Pain Management

What is Cancer of Unknown Primary?

Proto-Oncogene Activation: The Genetic Shift that Fuels Cancer

Transforming Cancer Care through Genomic Testing

Latest Cancer News and Research

Study identifies Piezo channels as targets for orthodontic care

A new review in Genes & Diseases highlights Piezo channels as important biological links between mechanical forces and the cellular processes that shape the face, move teeth and influence oral health.

12 Oct 2026

Long non-coding RNAs offer new pathways to overcome cancer treatment resistance

Scientists are highlighting long non-coding RNAs (lncRNAs) as promising targets in the effort to overcome one of cancer treatment's most persistent challenges: therapeutic resistance.

12 Oct 2026

RNA modification enzyme FTO shows therapeutic promise in gastrointestinal cancers

A new review in Genes & Diseases highlights FTO, an enzyme involved in RNA modification, as a potentially important biomarker and therapeutic target across gastrointestinal cancers.

12 Oct 2026

Review highlights EP4 receptor as target for inflammatory diseases

A review published in Genes & Diseases highlights the prostaglandin E2 receptor subtype 4 (EP4) as an important regulator of inflammation and a promising therapeutic target for a wide range of inflammatory and inflammation-related diseases.

12 Oct 2026

Targeting mitochondrial vulnerabilities could help treat triple-negative breast cancer

A deeper understanding of mitochondrial function could create new opportunities for treating triple-negative breast cancer (TNBC), one of the most aggressive and difficult-to-treat forms of breast cancer.

12 Oct 2026

Targeting lipophagy could help treat metabolic and oxidative stress-related diseases

A review published in Genes & Diseases highlights lipophagy, the cellular process that selectively breaks down lipid droplets, as a potentially important therapeutic target for conditions driven by disrupted lipid metabolism and oxidative stress.

12 Oct 2026

New review highlights expanding potential of therapeutic DNA vaccines

A new review published in Genes & Diseases highlights the expanding potential of DNA-based vaccines as a flexible platform for preventing infectious diseases, treating cancer and strengthening preparedness for future disease outbreaks.

12 Oct 2026

Buck Institute and Georgetown lead effort mapping harmful protein changes before disease begins

A research "super team" co-led by theBuck Institute for Research on Aging and Georgetown University has received an award of up to $51.7 million from the Advanced Research Projects Agency for Health (ARPA-H) to predict how disease-causing proteins misfold before irreversible damage occurs and use those predictions to develop novel diagnostics and treatments.

12 Oct 2026

Oregon's licensed psilocybin centers prioritize safety but remain highly expensive

A new study has found that Oregon's licensed psilocybin centers largely follow recommended safety guidelines, offering reassurance about how the first regulated psilocybin programs in the U.S. function in practice - though the cost of treatment may keep it out of reach for many.

12 Oct 2026

Magnetically guided millirobots deliver targeted drugs to beating hearts

Johns Hopkins University engineers have created robots the size of a pencil tip intended to travel through the body to deliver medicine to infections inside a beating heart.

12 Oct 2026

Study maps psychological networks linked to suicidal ideation

Suicidal ideation can involve interconnected psychological processes. Researchers from Pusan National University examined 2,018 adults across Italy, Korea, the UK, and the US to map psychosocial networks related to suicidal ideation.

12 Oct 2026

Most online breast cancer diet advice lacks strong evidence

Over 87% of online breast cancer nutrition claims lack strong scientific support, study finds.

12 Oct 2026

Amphista Therapeutics announces first patient dosed in AMX-883 Phase 1 clinical trial for acute myeloid leukemia

Amphista Therapeutics Limited ('Amphista'), a leader in the discovery and development of non-cereblon / VHL targeted protein degradation (TPD) medicines, today announced dosing of the first patient in a Phase 1 trial for its lead candidate, AMX-883. Initiated following authorization from the U.S. Food and Drug Administration in June 2026, the BRAMLIE trial will investigate the safety, pharmacokinetics, and preliminary efficacy of AMX-883 monotherapy in participants with AML and high-risk MDS.

From Amphista Therapeutics 12 Oct 2026

Study reveals continued care delays among patients with young-onset breast cancer

In an analysis of data on adolescents and young adults with breast cancer, lower income and younger age were linked with delays in care.

12 Oct 2026

HPV vaccines protect against cancer. Could they benefit pregnancy?

Findings from a nationwide study suggest HPV vaccination may reduce adverse pregnancy outcomes, emphasizing its importance in reproductive health strategies.

12 Oct 2026

Adding a chatbot to specialist care helped young people make sense of cancer risk

In a randomized trial of 106 adolescents and young adults with hereditary cancer predisposition, adding AYA-RISE to a clinic visit improved knowledge of cancer risk before age 30 compared with a clinic visit alone. Researchers observed no increase in distress, but the main analyses did not establish additional benefits for lifetime-risk or screening knowledge.

12 Oct 2026

What people ate at the start of a 20-year study was linked to their heart failure odds

Researchers linked higher baseline diet quality to lower odds of developing heart failure over 20 years among 2,159 Greek adults initially free of cardiovascular disease. Healthy-food consumption showed the most consistent association, but the observational study cannot establish that dietary changes prevent heart failure.

11 Oct 2026

Better blood pressure control could prevent over 518,000 annual deaths worldwide

Effective management of high blood pressure could prevent more than 518,000 annual deaths from cardiovascular disease around the world, according to preliminary research presented at the American Heart Association's Hypertension Scientific Sessions 2026.

11 Oct 2026

A trial of 3,220 smokers puts cash rewards for quitting to the test

In a randomized trial of 3,220 medically underserved adults referred for lung cancer screening, adding financial incentives to usual care and free medication increased sustained smoking abstinence at six months. Offering free medication alone did not significantly increase quit rates, and adding a forward-looking mobile tool did not improve outcomes beyond the incentives.

11 Oct 2026

Scientists identify the neuroblastoma cells that signal poor outcomes

Neuroblastoma is the most common solid tumor found outside of the brain in children, yet why some children respond well to treatment while others do not has remained poorly understood.

10 Oct 2026